Professional Experience

Senior Nurse Scientist, Wilmot Cancer Center,

Wilmot Cancer Center (Research), Rochester, NY. 2023 - Current

Associate Professor of Clinical Nursing,

University of Rochester (Research & Education), Rochester, NY, US. 2022 - Current

Nurse Practitioner, Wilmot Cancer Institute,

University of Rochester (Blood and Marrow Transplantation), Rochester, NY, US. 1998 - Current

Nurse Scientist, Wilmot Cancer Institute,

University of Rochester (Research), Rochester, NY, US. 2016 - 2023

Assistant Professor of Clinical Nursing,

University of Rochester (Research & Education), Rochester, NY, US. 6/2016 - 10/2022

Awards

Drs. Jeremy A. Klainer and Pamela York Klainer Endowed Dean’s Discretionary Award

UR School of Nursing, 2025

House of Delegates, Epsilon Xi Chapter Representative

Sigma Theta Tau, 2021

Presentations

APP-ONC: Advanced Practice Providers Caring for Cancer Survivors Outside of Oncology Settings

Lauren Ghazal

UR School of Nursing Brown Bag Research Series, UR School of Nursing, 2026

Rochester, New York

Cancer in Primary Care

2026 University of Rochester School of Nursing Advanced Practice Adult Gerontology Primary Care and Family Nurse Practitioner Program Guest Lecture Series, Wilmot Cancer Institute, 2026

Rochester, New York

Curious Minds Build Better Care: Innovation & Clinical Inquiry

Wilmot Cancer Institute Nurse Research Education Initiative, Wilmot Cancer Institute, 2025

Rochester, New York

Cancer in Primary Care

2025 University of Rochester School of Nursing Advanced Practice Adult Gerontology Primary Care and Family Nurse Practitioner Program Guest Lecture Series, Wilmot Cancer Institute, 2025

Rochester, New York

The Feasibility and Usability of a Mobile Phone Application for Chronic Graft-Versus-Host Disease Symptom Tracking

Dr. KC Clevenger

2024 Western NY Finger Lakes Region Innovation Conference, Wilmot Cancer Institute, 2024

Rochester, New York

Use of a Mobile Phone Application for Chronic Graft-Versus-Host Disease Symptom Tracking and is Effects on Symptom Reporting and Disease Severity

2023 Western NY Finger Lakes Region Innovation Conference, Wilmot Cancer Institute, 2023

Buffalo, New York

Hematologic Malignancies

2022 University of Rochester School of Nursing Advanced Practice Pediatric Nurse Practitioner Program Guest Lecture Series, Wilmot Cancer Institute, 2022

Rochester, New York

Some Simple Ways to Turn Your Clinical Question into a Workable Project

Kelly Clark BS, RN

2021 WCI Nursing Research Conference, Wilmot Cancer Institute, 2021

Rochester, New York

Heritable Hematologic Malignancies

2021 University of Rochester School of Nursing Advanced Practice Pediatric Nurse Practitioner Program Guest Lecture Series, Wilmot Cancer Center, 2021

Rochester, New York

Cancer in Primary Care

2021 University of Rochester School of Nursing Advanced Practice Adult Gerontology Primary Care and Family Nurse Practitioner Program Guest Lecture Series, Wilmot Cancer Institute, 2021

Rochester, New York

Managing the Care of the Research Participant Workshop Co-coordinator December 2019

Kelly Clark BS, RN & Jamie Littleton MS, RN

Oncology Nursing Research Workshop, Wilmot Cancer Institute, 2019

Rochester, New York

Publications

• Palermo, B. & Oliva, J. L. (2023). Chapter 9: Evidence-based standards of hematology & oncology practice.. Textbook for the adultgerontology acute care nurse practitioner: Evidence-based standards of practice. (1st ed.).
  
  
• Andolina, J. R., Walia, R., Oliva, J., Baran, J., Liesveld, J., Becker, M. W., Busacco, A., & Coppage, M. (2020). Non-donor specific anti-human leukocyte antigen (HLA) antibodies are not associated with poor outcome in hematopoietic stem cell transplant recipients.. Human Immunology, 81 (8), 407-412. PMID: 32471661 DOI: 10.1016/j.humimm.2020.05.006
  
  
• Hashmi, S., Oliva J. L.*, Liesveld, J. L., Phillips, G. L. 2nd, Milner, L., Becker, M. W. (*Contributions. SH and JLO contributed equally to all sections of the manuscript) (2013). The hematopoietic cell transplantation specific comorbidity index and survival after extracorporeal photopheresis, pentostatin, and reduced dose total body irradiation conditioning prior to allogeneic stem cell transplantation. Leukemia Research, 37 (9), 1052-6. PMID: 23830733 DOI: 10.1016/j.leukres.2013.06.013
  
  
• Keller, S. F., Kelly, J. L,, Sensenig, E., Andreozzi, J., Oliva, J., Rich, L., Constine, L., Becker. M., Phillips, G., Liesveld, J., Fisher, R. I., Bernstein, S.H., Friedberg, J. W. (2011). Late Relapses Following High-Dose Autologous Stem Cell Transplantation (HD-ASCT) for Hodgkin Lymphoma (HL) in the ABVD Therapeutic Era. Biology of Blood and Marrow Transplantation, 18 (4), 640-627. PMID: 21871246 PMCID: PMC3269502 DOI: 10.1016/j.bbmt.2011.08.012